Spire Healthcare sees FY in line, no impact from tariffs.
Spire Healthcare on Wednesday held guidance and said it expected no hit to its supply chain from US tariffs.
Source: Sharecast
The company said trading in the first four months of the year had been in line with expectations.
“Furthermore, our on-going transformation programme, which is expected to deliver at least £30m in efficiencies during FY25, remains on track with benefits weighted towards the second half of the year,” it added in a trading statement.
“As a business with 100% direct UK revenue exposure, we do not currently anticipate any material cost or supply chain impacts as a result of recent tariff announcements.”
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
